Description:Monograph Capital is a venture capital firm established with the mission of investing in life sciences companies focused on the development of innovative therapeutics, diagnostics, and technology-enabled business services aimed at enhancing healthcare outcomes. The firm operates from its primary offices located in London, San Francisco, and the Dallas-Fort Worth area, allowing it to effectively bridge investment opportunities across North America, the United Kingdom, and Europe.
The team at Monograph Capital comprises professionals with decades of experience in biomedical research and clinical medicine, as well as a collective total of over 55 years of investment experience specifically within the healthcare sector. This extensive background empowers Monograph to play an active role in fostering the growth of emerging organizations, transforming them into successful biotechnology firms and related life sciences businesses.
Monograph Capital is adept at identifying opportunities that have the potential to lead to significant advancements in healthcare outcomes, consistently engaging with innovative companies to support their journey toward scalability and success within the life sciences landscape.